These results suggest that CCL20 produced by breast cancer cells elevates the osteoblastic RANKL/OPG ratio and that osteoblastic CCL20 also contributes to the invasiveness of breast cancer cells. The gene discussed is TNFRSF11B; the disease is breast cancer.